Bruce Booth, Director at Kymera Therapeutics, Inc. (KYMR), sold 252,948 shares at $29.96 ($7.6M) on 2023-01-11, disclosed to the SEC on 2023-01-13.
Open-market sale of $7.6M KYMR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.96 | 6,071 | $182K | 2.4% |
| 2 | $29.96 | 6,071 | $182K | 2.4% |
| 3 | $29.96 | 21,683 | $650K | 8.5% |
| 4 | $29.96 | 21,683 | $650K | 8.5% |
| 5 | $30.29 | 21,592 | $654K | 8.6% |
| 6 | $30.29 | 21,592 |
| $654K |
| 8.6% |
| 7 | $30.29 | 77,128 | $2.3M | 30.6% |
| 8 | $30.29 | 77,128 | $2.3M | 30.6% |
| Total | $30.22 avg | 252,948 | $7.6M | 100% |
| Filing → |
| KYMR | SELL | 2026-06-30 | $56.5M | — | Filing → |
| KYMR | SELL | 2026-06-25 | $34.8M | — | Filing → |
| KYMR | SELL | 2026-06-25 | $44.0M | — | Filing → |